http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Playa Bowls Enhances Leadership to Support North American Expansion
-
BACCARAT AND DEWAR'S BLENDED SCOTCH WHISKY RETURN TO THE TONY AWARDS WITH THE REVIVAL OF THEIR ICONIC SPEAKEASY EXPERIENCE
-
Chobani and U.S. Soccer Celebrate Top U.S. Men's National Team Players and All the People Who Helped Feed Their Dreams
-
Akto Joins Cloud Security Alliance as AI Corporate Member, Advancing Enterprise-Grade Security for the Agentic AI Era
-
PEPSI® LEVELS UP SOCCER MATCH DAY FOOD, MAKING EVERY BITE TASTE BETTER
-
Metabolon Expands Global Access to Metabolomics with the Metabolon Verus™ Metabolomics Profiling Kit
-
SBI Life collaborates with Datamatics to harness Agentic AI, redefining underwriting for smarter, future-ready risk assessment
-
Victory Live Named Preferred Secondary Ticketing Services Partner of Minor League Baseball
-
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
-
Noom Brings the Lab to the Living Room: New At-Home Biomarkers Test Kit Enables Members to See Exactly How GLP-1s and Healthy Habits Are Transforming Their Health
-
Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Living bandage accelerates healing across multiple wound types
-
Marotta Controls Earns Top Workplace New Jersey Recognition for Fifth Consecutive Year
-
American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
-
Green Rain Energy Holdings, Inc. (OTC: GREH) Advances Blockchain-Powered EV Infrastructure Strategy and Provides Shareholder Update
-
CU Hawai’i Federal Credit Union Selects Mahalo Banking to Elevate Digital Banking Experience
-
Palvella Therapeutics receives Yale-licensed patent for QTORIN pitavastatin
-
TG Therapeutics reports positive phase 3 trial for simplified BRIUMVI dosing
-
Benton Announces $2 Million Non-Brokered Unit Financing with Investment by Eric Sprott
-
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
-
Transforming Rural Health Care Through a First-of-its-Kind Collaborative
-
TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial
-
Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043
-
Erdene publishes 2026 shareholder letter, schedules annual meeting
-
Arrowhead presents obesity drug data showing liver fat reduction
-
Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026
-
Erdene Releases 2026 Shareholder Letter and Provides Investor Update Webcast
-
Korro to Present at the 2026 Jefferies Global Healthcare Conference
-
Infrastructure Capital announces the first dividend for the Infrastructure Capital Nasdaq Option Income ETF (QVOL)
-
TRU Precious Metals Corp. Announces Adoption of Semi-Annual Financial Reporting Under Coordinated Blanket Order 51-933
-
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Abitibi Metals Intersects 4.04% CuEq (3.63% Cu, 0.37 g/t Au) over 14 m within 1.48% CuEq (1.33% Cu, 0.13 g/t Au) over 46.7 m
-
/C O R R E C T I O N -- Infrastructure Capital Advisors/
-
Best Altcoins to Invest in? BTC and Falcon Finance Soar as Whales Rush Into APEMARS’ Top 100X Coin Presale – Claim Bonus Before Launch Hits
-
Stratasys to acquire MarkForged for $42.5 million in all-cash deal
-
Stratasys to Acquire MarkForged, Inc., Expanding Aerospace, Defense, and Industrial Production Capabilities
-
Taylor Morrison is Certified™ by Great Place To Work® for the Second Consecutive Year
-
Little Pepe (LILPEPE) Presale Reaches $28 Million During Stage 13 Milestone Update
-
Societe Generale: Description of the share buy-back programme, subject to approval by the 2026 Annual General Meeting
-
Gilead's Livdelzi shows sustained liver marker improvement in PBC study
-
Phase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1–1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead’s Livdelzi (Seladelpar)
-
Missed XRP and Solana? APEMARS ICO Initial Coin Offering Gains Momentum as LAUNCH350 Bonus Code Fuels Top Crypto Presale Hype
-
7 Best Meme Coins to Buy Now Before June 8? Traders Say APEMARS Could Explode When Institutional Liquidity Floods Crypto Markets
-
Strategic Resources Submits Responses to Québec's Environment Ministry, Advancing Port Saguenay Iron Ore Pellet Plant Project
-
VEA NEWPORT BEACH ANNOUNCES "THE SECOND CITY GOES COASTAL" IN PARTNERSHIP WITH ACCLAIMED IMPROV COMEDY INSTITUTION, THE SECOND CITY
-
LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
-
Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit
-
Space Flight Laboratory Becomes New Private Company
-
Merck Announces Third-Quarter 2026 Dividend
-
Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF

